Evidence map›Paper›PMID 38326801›Full record

ArticleBMC urology2024

De-obstruction of bladder outlet in humans reverses organ remodelling by normalizing the expression of key transcription factors.

Akshay Akshay, Ali Hashemi Gheinani, Mustafa Besic, Sophie Braga, Anne-Christine Uldry, Manfred Heller, Hubert Rehrauer, Catharine Aquino Fournier, Fiona C Burkhard, Katia Monastyrskaya

Open access · goldAbstract read
In one paragraph

Article in BMC urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Akshay AkshayFunctional Urology Research Laboratory, Department for BioMedical Research DBMR, University of Bern, Bern, Switzerland.
Ali Hashemi GheinaniFunctional Urology Research Laboratory, Department for BioMedical Research DBMR, University of Bern, Bern, Switzerland.
Mustafa BesicFunctional Urology Research Laboratory, Department for BioMedical Research DBMR, University of Bern, Bern, Switzerland.
Sophie BragaProteomics and Mass Spectrometry Core Facility, DBMR University of Bern, Bern, Switzerland.
Anne-Christine UldryProteomics and Mass Spectrometry Core Facility, DBMR University of Bern, Bern, Switzerland.
Manfred HellerProteomics and Mass Spectrometry Core Facility, DBMR University of Bern, Bern, Switzerland.
Hubert RehrauerFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Catharine Aquino FournierFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
Fiona C BurkhardDepartment of Urology, Inselspital University Hospital, 3010, Bern, Switzerland.
Katia MonastyrskayaFunctional Urology Research Laboratory, Department for BioMedical Research DBMR, University of Bern, Bern, Switzerland. katia.monastyrskaia@unibe.ch.
University of Bern · CHUniversity Hospital of Bern · CHETH Zurich · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBenign prostatic hyperplasia in elderly males often causes bladder outlet obstruction termed benign prostatic obstruction (BPO). BPO induces lower urinary tract symptoms and quantifiable urodynamic alterations in bladder function. When conservative medical treatments are exhausted, surgical interventions like transurethral resection of the prostate (TURP) are employed for bladder outlet de-obstruction. Elucidating the molecular changes in the human bladder resulting from BPO and their reversal post-de-obstruction is pivotal for defining the "point of no return", when the organ deterioration becomes irreversible. In this study we carried out a comprehensive molecular and urodynamic characterization of the bladders in men with BPO before TURP and 3 months after the relief of obstruction.

methodsWe report integrated transcriptome and proteome analysis of bladder samples from male patients with BPO before and 3 months after de-obstruction surgery (TURP). mRNA and protein profiles were correlated with urodynamic findings, specifically voiding detrusor pressure (PdetQmax) before TURP. We delineated the molecular classifiers of each group, pointing at the different pre-TURP bladder status.

resultsAge-matched patients with BPO without DO were divided into two groups based on the PdetQmax values recorded by UDI before de-obstruction: high and medium pressure (HP and MP) groups. Three months after de-obstruction surgery, the voiding parameters PdetQmax, Qmax and RV were significantly improved in both groups, without notable inter-group differences in the values after TURP. Patients with high PdetQmax showed less advanced remodeling and inflammatory changes than those with lower values. We detected significant dysregulation of gene expression, which was at least partially reversed by de-obstruction in both patients' groups. Transcription factor SOX21 and its target thrombospondin 4 (THBS4) demonstrated normalization post-TURP.

conclusionsOur findings reveal substantial yet incomplete reversal of cell signalling pathways three months after TURP, consistent with improved urodynamic parameters. We propose a set of biomarker genes, indicative of BPO, and possibly contributing to the bladder changes. This study unveils the stages of progressive obstruction-induced bladder decompensation and offers insights into selecting an optimal intervention point to mitigate loss of contractility.

Indexed as

Prostatic HyperplasiaTransurethral Resection of ProstateUrinary Bladder Neck ObstructionAgedHumansMaleProstateTranscription FactorsUrinary BladderUrodynamicsTranscription FactorsBladderGene expressionObstructionOmicsUrodynamics

Identifiers

PMID38326801
PMCPMC10848355
OpenAlexW4391605927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.